Back to top
more

Cabot (CBT)

(Delayed Data from NYSE)

$72.00 USD

72.00
734,837

-0.18 (-0.25%)

Updated Aug 1, 2025 03:59 PM ET

After-Market: $72.10 +0.10 (0.14%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (233 out of 246)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Cabot's (CBT) Earnings and Revenues Beat Estimates in Q1

by Zacks Equity Research

The rise in Cabot's (CBT) Reinforcement Materials segment's EBIT is primarily driven by greater unit margins resulting from increased pricing and product mix in Q1.

Zacks Equity Research

Are You Looking for a High-Growth Dividend Stock?

by Zacks Equity Research

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cabot (CBT) have what it takes? Let's find out.

Zacks Equity Research

Koppers (KOP) Shares Surge 30% in 3 Months: What's Driving It?

by Zacks Equity Research

Koppers' (KOP) rally reflects a solid financial performance, driven by impressive growth in the Railroad and Utility Products and Services and Performance Chemicals segments.

Zacks Equity Research

Here's Why You Should Add DuPont (DD) to Your Portfolio Now

by Zacks Equity Research

DuPont (DD) benefits from innovation, the Spectrum Plastics acquisition and pricing and productivity actions.

Zacks Equity Research

Eastman Chemical (EMN) Shares Pop 17% in 3 Months: Here's Why

by Zacks Equity Research

Eastman Chemical (EMN) gains on cost-management actions and innovation and maintains a disciplined approach to capital allocation.

Zacks Equity Research

Best Value Stocks to Buy for January 15th

by Zacks Equity Research

RGA, PAX and CBT made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 15, 2024.

Zacks Equity Research

Arkema (ARKAY) Backs Tiamat for Lithium-Free Battery Innovation

by Zacks Equity Research

Arkema (ARKAY) invests in Tiamat, accelerating the development of lithium-free solutions and supporting the construction of a dedicated 5 GWh Giga-factory in France.

Zacks Equity Research

New Strong Buy Stocks for January 15th

by Zacks Equity Research

CBT, BROS, WRK, ROCK and CBOE have been added to the Zacks Rank #1 (Strong Buy) List on January 15, 2024.

Zacks Equity Research

Daqo (DQ) Issues Update on $700M Share Repurchase Program

by Zacks Equity Research

Daqo New Energy (DQ) repurchased shares worth $491 million by 2023 end, expressing confidence in undervaluation and emphasizing capital preservation amid industry challenges.

Zacks Equity Research

Here's Why Cabot (CBT) is a Strong Value Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

Here's Why You Should Retain Nutrien (NTR) in Your Portfolio

by Zacks Equity Research

While Nutrien (NTR) faces challenges from softer fertilizer prices, it gains on strong demand for crop nutrients on the strength in global agriculture markets.

Zacks Equity Research

ArcelorMittal (MT) to Restart Bosnia Plant After Two-Month Halt

by Zacks Equity Research

ArcelorMittal (MT) plans to restart its Bosnia plant after a November shutdown due to declining steel demand in Europe, influenced by the Ukraine war and rising costs.

Zacks Equity Research

Celanese (CE) Gains on Acquisitions & Productivity Actions

by Zacks Equity Research

While Celanese (CE) faces headwinds from weaker demand and de-stocking, it benefits from productivity measures, investments in organic projects and strategic acquisitions.

Zacks Equity Research

Intrepid (IPI) Enters Into Third Amendment to Agreement With XTO

by Zacks Equity Research

Intrepid Potash (IPI) secures strategic gains with XTO Holdings, enhancing cooperation and shareholder value in the Designated Potash Area.

Zacks Equity Research

BASF (BASFY) & Stena Partner for Europe's EV Battery Recycling

by Zacks Equity Research

BASF (BASFY) and Stena Recycling will create a circular battery recycling system for European electric vehicles, emphasizing high metal recovery rates and a reduced carbon footprint.

Zacks Equity Research

Reliance Steel (RS) Shares Up 32% in a Year: What's Driving It?

by Zacks Equity Research

Reliance Steel (RS) benefits from strong underlying demand in its major markets and strategic acquisitions.

Zacks Equity Research

Innospec's (IOSP) Stock Up 14% in 3 Months: Here's Why

by Zacks Equity Research

Innospec (IOSP) benefits from the strength in its Oilfield Services unit and strategic growth measures.

Zacks Equity Research

Universal Stainless (USAP) Surges 76% in 3 Months: Here's Why

by Zacks Equity Research

The strong momentum in Universal Stainless' (USAP) stock reflects a stellar performance in the third quarter, primarily driven by record sales in the aerospace sector.

Zacks Equity Research

ArcelorMittal (MT) Rejects Italy Government's Stake Plan in ADI

by Zacks Equity Research

ArcelorMittal (MT) rejects the Italian government's proposal to acquire a controlling stake in ADI, a major steel plant, citing reluctance to commit financially, sparking concerns over the future of the financially troubled ex-Ilva plant in Taranto.

Zacks Equity Research

Here's Why You Should Buy Eastman Chemical (EMN) Stock Right Now

by Zacks Equity Research

Eastman Chemical (EMN) benefits from cost-management actions, operational execution and innovation.

Zacks Equity Research

Why Should You Add Air Products (APD) Stock to Your Portfolio

by Zacks Equity Research

Air Products (APD) benefits from its investments in high-return industrial gas projects, project wins and productivity initiatives.

Zacks Equity Research

Cabot (CBT) Upgraded to Buy: What Does It Mean for the Stock?

by Zacks Equity Research

Cabot (CBT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Why Cabot (CBT) is a Great Dividend Stock Right Now

by Zacks Equity Research

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cabot (CBT) have what it takes? Let's find out.

Zacks Equity Research

CBT or AIQUY: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

CBT vs. AIQUY: Which Stock Is the Better Value Option?

Zacks Equity Research

Is Cabot (CBT) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.